In search of new targets for plasma high-density lipoprotein cholesterol levels: promise of human-mouse comparative genomics.
see Reprint Collection
Trends Cardiovasc Med 2006 Oct; 16(7):220-34.
Many lines of evidence suggest that raising plasma high-density lipoprotein cholesterol (HDL-C) levels may inhibit, perhaps even reverse, atherosclerosis. Quantitative trait locus (QTL) analysis has been performed in both humans and mice. So far, approximately 40 high-density lipoprotein (HDL)-regulating QTLs have been identified in each species. To compare human and mouse HDL-C QTLs, we generate human-mouse comparative chromosome maps based on homologous genes in humans and mice. The comparative maps reveal that most human and mouse HDL-C QTLs are concordant, which suggests that identifying the underlying QTL genes in mice will facilitate identifying their homologs in humans. The maps also help to narrow QTLs by mouse-human homologous QTL comparison. By using a combination of classic genetic approaches and newer bioinformatics tools (including comparative genomics as highlighted in this study), identifying new drug targets for plasma HDL-C levels holds more promise than ever.
Rollins, J; Chen, Y; Paigen, B; and Wang, X, "In search of new targets for plasma high-density lipoprotein cholesterol levels: promise of human-mouse comparative genomics." (2006). Faculty Research 2000 - 2009. 1447.